Clinical Trials on Culprit Plaque in Czechia
Total 32 results
-
University Hospital OstravaCharles University, Czech Republic; University Hospital Olomouc; University of... and other collaboratorsActive, not recruiting
-
Na Homolce HospitalMinistry of Health, Czech RepublicActive, not recruiting
-
University Hospital, Motolprofessor Josef Veselka; associate professor Petr Hájek; Martin HorváthCompletedCarotid Atherosclerosis | Restenosis | Carotid Artery Stenting | Near Infrared Spectroscopy | Atherosclerotic PlaqueCzechia
-
Biocon Biologics Inc.MEDA Pharma GmbH & Co. KG; Mylan Inc.; IQVIA Pvt. LtdCompletedHulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and ImmunogenicityModerate Chronic Plaque Psoriasis | Severe Chronic Plaque PsoriasisBulgaria, Czechia, Estonia, Poland
-
Samsung Bioepis Co., Ltd.Organon and CoCompletedPlaque PsoriasisCzechia, Lithuania, Poland, Bulgaria
-
Fresenius Kabi SwissBioSim GmbHMerck KGaA, Darmstadt, GermanyCompletedPsoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type PsoriasisUnited States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
-
Samsung Bioepis Co., Ltd.CompletedPsoriasis | Moderate to Severe Plaque PsoriasisCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Lithuania, Poland, Ukraine
-
UCB Biopharma S.P.R.L.CompletedPsoriasis | Plaque PsoriasisUnited States, Canada, Czechia, Germany, Hungary
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Canada, Czechia, Hungary, Japan, Poland
-
Momenta Pharmaceuticals, Inc.CompletedPsoriasis | Chronic Plaque PsoriasisUnited States, Poland, Canada, Czechia, Estonia, Germany, Slovakia, Bulgaria, Latvia
-
UCB Biopharma SRLCompletedPlaque PsoriasisBelgium, Canada, Czechia, France, Germany, Greece, Italy, Spain, United Kingdom
-
UCB Biopharma S.P.R.L.ParexelCompletedChronic Plaque PsoriasisUnited States, Canada, Czechia, Hungary, Japan, Poland
-
Alumis IncCompletedPlaque PsoriasisUnited States, Canada, Czechia
-
DICE Therapeutics, Inc., a wholly owned subsidiary...Active, not recruitingPlaque PsoriasisCanada, Hungary, Germany, Spain, United States, Poland, United Kingdom, Czechia
-
PfizerCompletedPsoriasis | Plaque PsoriasisSpain, Taiwan, Germany, Korea, Republic of, Belgium, Greece, Hungary, Argentina, Austria, Czech Republic, Italy, Mexico, Thailand
-
NHS National Waiting Times Centre BoardStanford University; Catharina Ziekenhuis Eindhoven; Onze Lieve Vrouw Hospital; Brno University Hospital and other collaboratorsCompletedCoronary Artery Disease | Plaque, AtheroscleroticNetherlands, United States, Czech Republic, Belgium, Sweden
-
Eli Lilly and CompanyCompletedPlaque PsoriasisUnited States, Spain, Puerto Rico, Czechia, Canada, Germany, France, Poland, Hungary, Mexico, Russian Federation, Argentina, Netherlands
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisCzech Republic, Estonia, Hungary, Israel, Romania, Slovakia, Slovenia, Ukraine
-
Eli Lilly and CompanyCompletedPlaque PsoriasisArgentina, Puerto Rico, United States, Australia, Taiwan, Japan, Hungary, Korea, Republic of, Mexico, Germany, Poland, Romania, Czechia, Canada
-
UCB Biopharma S.P.R.L.CompletedPsoriasis | Plaque PsoriasisUnited States, Bulgaria, Czechia, France, Germany, Hungary, Netherlands, Poland, United Kingdom
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisUnited States, Hungary, Malaysia, Czechia, Korea, Republic of, Guatemala, Poland, Vietnam, Canada, Iceland, Slovakia
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisGermany, Belgium, Spain, Croatia, Czechia, Greece, Hungary, Russian Federation, Netherlands, Austria, France, Switzerland, Israel, United Kingdom, Italy, Lithuania, Sweden, Bulgaria, Denmark, Finland, Portugal, Slovakia, Poland, Latvia
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
SandozHexal AGCompletedChronic Stable Plaque PsoriasisGermany, Romania, Bulgaria, Czech Republic, Estonia, Hungary, Poland, Russian Federation, Slovakia, South Africa, Ukraine, United Kingdom
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
AbbottCompletedChronic Plaque PsoriasisBelgium, Denmark, France, Germany, Spain, Sweden, Switzerland, Finland, Turkey, Italy, Czech Republic, Austria, Netherlands, United Kingdom, Greece
-
AbbVieCompletedChronic Plaque PsoriasisUnited States, Austria, Canada, Czechia, Denmark, France, Germany, Greece, Ireland, Netherlands, Puerto Rico, Spain, Sweden, United Kingdom
-
AbbVieActive, not recruitingChronic Plaque PsoriasisArgentina, Australia, Austria, Canada, Colombia, Czechia, France, Germany, Hungary, Ireland, Italy, Japan, Mexico, Netherlands, Poland, Romania, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisGermany, United Kingdom, Belgium, Czechia, Estonia, Italy, France, Israel, Spain, Bulgaria, Lithuania, Portugal, Poland, Romania, Latvia, Greece, Slovakia